UFF
TARO

USA Financial Formulas’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

USA Financial Formulas’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-8,478
Closed -$989K – 329
2017
Q1 		$989K Sell
8,478
-2,308
-21% -$255K 0.24% 96
2016
Q4 		$1.14M Buy
10,786
+2,139
+25% +$224K 0.28% 76
2016
Q3 		$956K Buy
+8,647
New +$1.15M 0.25% 93
2015
Q3 		– Sell
-12,411
Closed -$1.78M – 213
2015
Q2 		$1.78M Buy
+12,411
New +$1.77M 0.55% 56

Other funds holding TARO

MICM
Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FL
Fort LP Chevy Chase, Maryland $39.6M AUM 37.11% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

USA Financial Formulas's TARO Position: Q2 2017 in Review

USA Financial Formulas sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q2 2017, closing a stake of 8,478 shares — an estimated $989K sold.

USA Financial Formulas first reported a position in TARO in Q2 2015 and held it in 4 quarters. The position peaked at $1.78M in Q2 2015. 140 funds tracked by Wall St. Rank hold TARO as of Q2 2017.

  • USA Financial Formulas reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q2 2017 after selling out during the quarter.
  • USA Financial Formulas sold 8,478 Taro Pharmaceutical Industries Ltd. shares in Q2 2017, an estimated $989K.
  • USA Financial Formulas first reported a position in Taro Pharmaceutical Industries Ltd. in Q2 2015 and held it in 4 quarters.
  • USA Financial Formulas's Taro Pharmaceutical Industries Ltd. position peaked at $1.78M in Q2 2015.
  • 140 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q2 2017.

Based on USA Financial Formulas's 13F filing for Q2 2017, filed 23 Aug 2017.